These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6827168)

  • 21. [3 cases of transfusion of the fetus "in utero" for severe feto-maternal blood incompatibility].
    Grosieux P; Barraya PL; Leroux JP; Aubert F; Rouchy R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):350-4. PubMed ID: 5479067
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 27. [Accidents caused by ABO type feto-maternal blood incompatibility].
    Chabrier J
    Rev Prat; 1965 Oct; 15(27):3550-6. PubMed ID: 5840867
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I; Schlenke P; Härtel C
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrauterine fetal transfusion.
    McGuiness EP; Reen DJ
    Br Med J; 1977 Jun; 1(6074):1469. PubMed ID: 405078
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticosteroids, real-time ultrasound scanning and plasmapheresis in severe rhesus disease.
    Gunston KD; Woods DL; Leader LR
    S Afr Med J; 1979 Oct; 56(17):666. PubMed ID: 117557
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of RH-HR blood group incompatibility].
    Seyfriedowa H
    Acta Haematol Pol; 1979 Oct; 10(4):221-6. PubMed ID: 120092
    [No Abstract]   [Full Text] [Related]  

  • 32. [What can be done for mother and infant in the case of irregular antibodies in pregnant Jehovah's witnesses?].
    van Roosmalen J; Kanhai HH; Ruys JH; Dupuis HM; Bennebroek Gravenhorst J
    Ned Tijdschr Geneeskd; 1987 May; 131(21):889-91. PubMed ID: 3587426
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma exchange therapy of maternofetal immune disease].
    Ukita M; Yagiri Y; Ueda Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():451-6. PubMed ID: 1578723
    [No Abstract]   [Full Text] [Related]  

  • 35. [Repeated plasmapheresis in severe Rhesus isoimmunization].
    Nublat M; Melis C; Boissieu G; Gaujoux J; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):227-30. PubMed ID: 4220061
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L; Huang X; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul; 33(7):406-8. PubMed ID: 10806699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment in Rh incompatibility.
    Lozińska D
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1111-5. PubMed ID: 107912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of maternal-fetal blood group incompatibility with traditional Chinese herbal medicine.
    Bian X; Xu Y; Zhu L; Gao P; Liu X; Liu S; Qian M; Gai M; Yang J; Wu Y
    Chin Med J (Engl); 1998 Jul; 111(7):585-7. PubMed ID: 11245041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red cell antigens. The fetus as a patient.
    Huntley B
    Lancet; 2001 Dec; 358 Suppl():S58. PubMed ID: 11784607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of anti-C+D+G (CD) caused by Rh-incompatible pregnancy].
    Nakamura Y; Sada I; Munakata S; Shinagawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):457-60. PubMed ID: 3920334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.